| Mrs Tracie Lee Beckmann, | |
|
731 Falcon Hill Trl, O Fallon, MO 63368-8194 | |
| (636) 448-0995 | |
| Not Available |
| Full Name | Mrs Tracie Lee Beckmann |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 731 Falcon Hill Trl, O Fallon, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083215768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 26793 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tracie Lee Beckmann, 731 Falcon Hill Trl, O Fallon, MO 63368-8194 Ph: (636) 448-0995 | Mrs Tracie Lee Beckmann, 731 Falcon Hill Trl, O Fallon, MO 63368-8194 Ph: (636) 448-0995 |
News Archive
The Associated Press: The new health law "starts delivering protections and dollars-and-cents benefits that Americans can grasp. But it won't affect all consumers the same way, which may cause confusion." The AP walks consumers through some of the provisions in a question and answer format (Johnson, 9/22).
The latest evidence on the prevention and management of heart failure will be showcased at Heart Failure 2021, an online scientific congress of the European Society of Cardiology (ESC).
A new study finds that the viral non-coding RNA dubbed vmiR-5p, derived from the viral gene ORF7a, appears to reduce host transcription.
In an attempt to correct defects in the energy generation that contribute to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure.
Discovery Laboratories, Inc. announces today that it has received written guidance from the U.S. Food and Drug Administration (FDA) that is consistent with its ongoing, comprehensive preclinical program to resolve the sole remaining chemistry, manufacturing & control (CMC) issue necessary to potentially gain FDA marketing approval for Surfaxin® (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants.
› Verified 7 days ago
Kristin K Weber, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7500 Highway N, O Fallon, MO 63368 Phone: 636-625-4537 Fax: 636-625-4447 | |
Nicole Leigh Hartrum, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 Virgil St, Special Services, O Fallon, MO 63366 Phone: 636-240-2072 Fax: 636-240-2072 | |
Allison Becker, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9233 Highway Dd, O Fallon, MO 63368 Phone: 636-625-1026 | |
Mrs. Loretta Marie Dunkmann, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Sunflower Ln, O Fallon, MO 63366 Phone: 636-272-2704 | |
Amy Grosch, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 610 Prince Ruppert Dr, O Fallon, MO 63366 Phone: 636-272-2709 | |
Mrs. Allison Mesler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Meriwether Lewis Dr, O Fallon, MO 63368 Phone: 636-281-3382 | |
Jessica Ann Elwell, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 Virgil St, O Fallon, MO 63366 Phone: 636-240-2072 Fax: 636-980-1946 |